Pre-order Enquiry
Request Free Sample
2020-2025 Global Pediatrics Medicine Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
SKU ID : Maia-17000291 | Publishing Date : 17-Dec-2020 | No. of pages : 116
Request Sample
Request Customization
Check Discounts
Pediatrics is the branch of medicine that involves the medical care of infants, children, and adolescents. The American Academy of Pediatrics recommends people be under pediatric care up to the age of 21. A medical doctor who specializes in this area is known as a pediatrician, or paediatrician. The word pediatrics and its cognates mean "healer of children"; they derive from two Greek words: παῖς (pais "child") and ἰατρός (iatros "doctor, healer"). Pediatricians work both in hospitals, particularly those working in its subspecialties such as neonatology, and as primary care physicians.
This report elaborates the market size, market characteristics, and market growth of the Pediatrics Medicine industry, and breaks down according to the type, application, and consumption area of Pediatrics Medicine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pediatrics Medicine in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Pediatrics Medicine market covered in Chapter 13:
Bristol-Myers Squibb
Pfizer
RedHill
Helsinn Healthcare
Heron Therapeutics
GSK
Novartis
Eisai Pharmaceuticals
Takeda Pharmaceutical
Ipca Laboratories
F. Hoffman-La Roche
Lupin Pharmaceuticals
Cipla
Abbott
Sanofi
Eli Lilly
Merck Sharp＆Dohme
Sun Pharmaceutical Industries
Glenmark
In Chapter 6, on the basis of types, the Pediatrics Medicine market from 2015 to 2025 is primarily split into:
Enteral
Parenteral
In Chapter 7, on the basis of applications, the Pediatrics Medicine market from 2015 to 2025 covers:
Respiratory diseases
Infectious diseases
Gastrointestinal diseases
CNS diseases
Oncological diseases
CVDs
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
2019
This report elaborates the market size, market characteristics, and market growth of the Pediatrics Medicine industry, and breaks down according to the type, application, and consumption area of Pediatrics Medicine. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pediatrics Medicine in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Pediatrics Medicine market covered in Chapter 13:
Bristol-Myers Squibb
Pfizer
RedHill
Helsinn Healthcare
Heron Therapeutics
GSK
Novartis
Eisai Pharmaceuticals
Takeda Pharmaceutical
Ipca Laboratories
F. Hoffman-La Roche
Lupin Pharmaceuticals
Cipla
Abbott
Sanofi
Eli Lilly
Merck Sharp＆Dohme
Sun Pharmaceutical Industries
Glenmark
In Chapter 6, on the basis of types, the Pediatrics Medicine market from 2015 to 2025 is primarily split into:
Enteral
Parenteral
In Chapter 7, on the basis of applications, the Pediatrics Medicine market from 2015 to 2025 covers:
Respiratory diseases
Infectious diseases
Gastrointestinal diseases
CNS diseases
Oncological diseases
CVDs
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
